Skip to content
ENT SurgicalTech & Protocols

IONM in Total Endoscopic Thyroidectomy: Improving RLN Identification and Expanding Surgical Indications

Retrospective cohort of 122 total endoscopic thyroidectomies shows IONM achieves 100% RLN identification, enables more lobectomies (28.9% vs 6.5%), and eliminates permanent nerve injury.

IP

Editorial Team

Clinical evidence review

7 min read
Source:Journal of Clinical Surgery (2017)DOI10.3969/j.issn.1005-6483.2017.11.013

Key Takeaways

  • IONM achieved a 100% Recurrent Laryngeal Nerve (RLN) identification rate in total endoscopic thyroidectomy (TET), compared with 72.7% (22/30) by visual inspection alone in the non-IONM group.
  • IONM enabled a significantly higher rate of total lobectomy (28.9% vs 6.5%, P = 0.001), allowing more patients with complex or multifocal disease to be offered a minimally invasive approach without added nerve risk.
  • No permanent RLN dysfunction occurred in either group; transient RLN injury was 2.2% in the IONM group versus 5.1% in the non-IONM total lobectomy subgroup.
  • Operative time was not significantly prolonged by IONM (118.7 ± 27.8 min vs 108.7 ± 28.0 min, P = 0.10), confirming the technique is feasible without meaningful workflow penalty.

Clinical Context

Total endoscopic thyroidectomy (TET) via a bilateral areolar–chest approach is an established, cosmetically superior alternative to open thyroidectomy. However, the confined endoscopic operative field and lack of direct tactile feedback elevate the risk of RLN injury, which remains one of the most consequential complications of the procedure. Reported rates of transient and permanent RLN injury in TET are approximately 3.6% and 0.3%–2.0%, respectively.

Intraoperative Neurophysiological Monitoring (IONM) is well validated in open and minimally invasive (e.g., Miccoli) thyroid surgery, where it reduces RLN injury risk through accurate localization and real-time functional surveillance. Its role in fully endoscopic TET, however, has been less well characterized. This study reports the experience of a high-volume tertiary surgical center (Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) with the systematic integration of IONM into TET, evaluating feasibility, RLN identification, and perioperative outcomes.

Clinical Evidence & Cohort Breakdown

This was a retrospective review of 122 consecutive patients undergoing TET between February 2014 and February 2016, stratified by whether IONM was used: IONM group (n = 45) and non-IONM group (n = 77). Procedures included unilateral or bilateral partial lobectomy and unilateral or bilateral total lobectomy. Follow-up was at least 6 months, with vocal fold assessment by laryngoscopy on postoperative day 1, week 1, month 1, and month 6.

Table 1. Baseline Characteristics

Parameter Non-IONM Group (n = 77) IONM Group (n = 45) P value
Age (years) 36.2 ± 10.2 36.4 ± 9.9 0.901
Female sex, n (%) 61 (79.2%) 31 (68.9%) 0.201
Male sex, n (%) 16 (20.8%) 14 (31.1%) —
Maximum nodule diameter (mm) 15.2 ± 10.6 17.2 ± 9.4 0.065
Multifocal disease, n (%) 3 (3.9%) 8 (17.8%) 0.018
Benign pathology, n (%) 75 (97.4%) 40 (88.9%) 0.099
Malignant pathology, n (%) 2 (2.6%) 5 (11.1%) —
Partial lobectomy, n (%) 72 (93.5%) 32 (71.1%) 0.001
Total lobectomy, n (%) 5 (6.5%) 13 (28.9%) 0.001

Table 2. Surgical and Neurological Outcomes

Parameter Non-IONM Group IONM Group P value
Operative time (min) 108.7 ± 28.0 118.7 ± 27.8 0.10
RLN identification rate (%) 72.7% (22/30) 100.0% (75/75) —
Postoperative drainage volume (mL) 188.6 ± 44.6 175.2 ± 37.2 0.11
Mean hospital stay (days) 5.8 ± 0.8 5.5 ± 1.0 0.066
Transient RLN injury — partial lobectomy, n (%) 1 (1.2%) 0 (0%) —
Transient RLN injury — total lobectomy, n (%) 4 (5.1%) 1 (2.2%) —
Permanent RLN injury, n 0 0 —

The single transient RLN injury in the IONM group was attributed to thermal injury from prolonged use of the harmonic scalpel, with the active blade tip generating heat in close proximity to the nerve—an injury mechanism not detectable by visual inspection alone. All transient injuries recovered normal vocal fold mobility and phonation by 6 months.

Intraoperative IONM Protocol & Technical Pearls

The following step-by-step protocol reflects the technique used at the source center and can be adapted to standard EMG-based IONM systems.

  1. Anesthesia and EMG Endotracheal Tube (EMG Tube) placement. Following the manufacturer's manual, place the EMG endotracheal tube with surface electrodes at the vocal fold level and confirm correct positioning under direct vision. Connect to the monitoring console (Medtronic NIM 3.0 system) and verify impedance and baseline signal before incision. Avoid neuromuscular blockade (NMB) residual at the time of neural stimulation.

  2. Patient positioning and port placement. Position the patient supine with arms abducted 90°, legs abducted 30–45°, shoulders elevated 10–15°, and head extended 10–15°. Mark the nodule projection, medial border of the sternocleidomastoid, midline, suprasternal notch, and clavicle. Create a 5-mm incision at the superomedial areolar border bilaterally for instruments and a 10-mm incision at the inframammary fold near the medial right breast for the endoscope.

  3. Subplatysmal dissection and CO₂ insufflation. Dissect the subcutaneous plane between the superficial fascia of the chest and the deep surface of the platysma, extending cephalad to the upper pole of the thyroid and laterally to the anterior border of the sternocleidomastoid. Maintain CO₂ pressure at 6–7 mmHg.

  4. Dedicated monitoring access port. Puncture the operative cavity at the midpoint of the medial border of the ipsilateral sternocleidomastoid using a 60-mL syringe needle. Through this small stab incision, introduce a specially designed retractor to retract the strap muscles and sternocleidomastoid laterally for improved exposure. This same port is later used to introduce the Monopolar stimulating probe, minimizing additional cosmetic impact.

  5. Visual identification of the RLN. Identify the candidate nerve as a white, glistening cord-like structure on the posterior thyroid capsule, with 1–2 fine surface vessels, running parallel to the trachea toward the cricothyroid muscle at the Berry ligament.

  6. Electrophysiological confirmation. Withdraw the retractor and introduce the Monopolar stimulating probe through the same puncture port. Apply intermittent electrical stimulation and record EMG Amplitude (μV). Confirm RLN identity when the evoked EMG signal exceeds three times the baseline or background reading and is no less than 150 μV.

  7. Functional surveillance during dissection. Repeat stimulation at intervals throughout gland mobilization—particularly near the Berry ligament and inferior pole—to track functional integrity in real time. Note that thermal injury from the harmonic scalpel may not produce immediate visual changes; rely on signal changes to detect evolving injury.

  8. Postoperative vocal fold assessment. Evaluate phonation and vocal fold function on postoperative day 1, week 1, month 1, and month 6. Define transient RLN injury as recovery of vocal fold mobility within 6 months and permanent RLN injury as vocal cord paralysis (VCP) persisting beyond 6 months.

Clinical Implications for Surgeons & IONM Specialists

  • IONM converts visual guesswork into electrophysiological certainty. In the non-IONM group, RLN identification was possible in only 72.7% of nerves requiring identification, versus 100% with IONM. In the endoscopic field—where anatomical distortion from insufflation and limited tactile feedback prevail—this difference is clinically decisive.

  • IONM expands the indications for TET. The IONM group included significantly more multifocal disease (17.8% vs 3.9%) and underwent total lobectomy far more often (28.9% vs 6.5%). Early in the program, case selection without IONM was deliberately conservative; with monitoring available, more complex disease could be safely offered a minimally invasive approach without an increase in complications.

  • Thermal injury is an underappreciated mechanism. The one transient injury in the IONM group was a thermal injury from the harmonic scalpel, invisible to direct inspection. IONM provides the only practical means of detecting such evolving functional compromise intraoperatively.

  • The dedicated stab port is a practical, low-cost adjunct. A single small puncture serves both for retractor placement (improving exposure of the strap muscles and sternocleidomastoid) and for probe introduction, with negligible cosmetic consequence.

  • Cost-effectiveness should be weighed against risk. Although IONM adds cost, the reduction in RLN injury risk—and the associated medicolegal exposure—supports its routine consideration in TET, particularly for total lobectomy and complex cases.

  • Limitations. This is a retrospective, single-center analysis with a modest sample size and non-randomized allocation; selection bias (reflected in the differing lobectomy and multifocal rates) likely influenced outcomes. Optimal indications and refinements in probe technique in the endoscopic setting warrant further prospective study.

Reference

Dong H, Yi J, Liu J, Li X, Kang M, Yin Q. Application of intraoperative neuromonitoring system in total endoscopic thyroidectomy. Journal of Clinical Surgery (Lin Chuang Wai Ke Za Zhi). 2017;25(11):840–842. DOI: 10.3969/j.issn.1005-6483.2017.11.013.

Medical Disclaimer: This article is provided for educational and informational purposes only and does not constitute medical advice. Clinical decisions regarding the use of IONM, surgical technique, and patient selection should be made by qualified healthcare professionals based on individual patient circumstances and current institutional protocols. The summarized findings reflect the original study's design and population and may not be generalizable to all practice settings.

Medical disclaimer

This protocol is provided for clinical education and reference only. It does not constitute medical advice, a standard of care, or a substitute for surgeon judgment, institutional policy, device labeling, or patient-specific assessment. Verify all stimulation parameters, electrode compatibility and indications against current manufacturer instructions before use. Read the full disclaimer.

Continue the protocol

Related guidance

View the IONM library